The US Food & Drug Administration performs Pre-Approval Inspections (PAIs) and Regular Inspections of our facilities under the Federal Food, Drug, and Cosmetic (FD&C) Act. 

AmbioPharm complies with all FDA inspections and PAIs while demonstrating a consistent commitment to the highest levels of quality and compliance. 

You can look us up on the FDA website here:

https://datadashboard.fda.gov/ora/cd/inspections.htm

Our inspection history is available to clients and partners upon request.